Correction of a heterozygous PKCβ mutation via genome editing suppressed anchorage-independent growth and reduced CRC growth in a xenograft model, indicating that PKCβ has a tumor suppressive function.14 The gene discussed is PRKCB; the disease is colorectal carcinoma.